author={Barbara L. Herwaldt},
  journal={The Lancet},

Figures from this paper

Cutaneous Leishmaniasis Caused by an Unknown Leishmania Strain, Arizona, USA

This parasite was classified into the subgenus Leishmania on the basis of multilocus DNA sequence and phylogenetic analyses of the rRNA locus and 11 reference genes.

Methylglyoxal metabolism in Leishmania infantum

Tese de doutoramento, Bioquimica (Regulacao Bioquimica), Universidade de Lisboa, Faculdade de Ciencias, 2010.

Prevention strategies of transfusion‐transmitted parasitic infections (TTPIs) in Iran, an endemic area for malaria, toxoplasmosis and leishmaniasis

The objective of this work was to clarify and describe the strategies to minimize the transmission risk of endemic parasitic agents in Iran via blood transfusion.

Cutaneous Leishmaniasis due to Leishmania (Viannia) panamensis in Two Travelers Successfully Treated with Miltefosine.

It is suggested that miltefosine represents an important therapeutic alternative in the treatment of cutaneous lesions caused by L. panamensis and in preventing mucosal involvement.

Chemotherapy of leishmaniasis part-VIII: synthesis and bioevaluation of novel chalcones.

Visceral leishmaniasis mimicking systemic lupus erythematosus.

The first case of autochthonous VL mimicking SLE is presented in Santa Catarina in southern Brazil, and may be associated with autoimmune phenomena, including simulating systemic lupus erythematosus (SLE).

A Review of Leishmaniasis: Current Knowledge and Future Directions

The goal of this review is to summarize the current knowledge of the epidemiology, clinical manifestations, diagnosis, and treatment of cutaneous, mucosal, and visceral leishmaniasis. We will

Otolaryngologic Presentation of Mucosal Leishmaniasis

This case highlights the necessity of obtaining accurate travel and social history and the often delayed presentation of mucosal leishmaniasis.

Potential role of zinc in the visceromegaly regression and recovery of hematological parameters during treatment of visceral leishmaniasis in children from an endemic area

The administration of zinc in children with visceral leishmaniasis, during treatment with amphotericin B or glucantime, accelerates the regression of the spleen enlargement without interfering with the recovery of hematological parameters.




Summary.— A case of post kala‐azar dermal leishmaniasis is reported to illustrate the late onset of the dermal changes and the difficulties of diagnosis.

Kala-azar (visceral leishmaniasis): report of a case with 34 month incubation period and positive Doan-Wright test.

Excerpt Since World War II there have been numerous reports of the occurrence of kala-azar in service men returning from endemic areas in the Mediterranean coastal countries,1, 2, 3, 4, 5, 6, 7Indi...

Treatment of Cutaneous Leishmaniasis with Infrared Heat

Patients having cutaneous leishmaniasis were treated by exposing the largest lesion once to a source of infrared heat, provokes an immune response in the patient and allows the lesions to disappear in approximately 5–6 weeks.

T-cell and cytokine responses in leishmaniasis.

TH1 and TH2 cell antigen receptors in experimental leishmaniasis.

Analysis of the T cell receptor repertoire used by mice infected with Leishmania major revealed the expansion of a restricted population of CD4+ cells, suggesting that candidate vaccine antigens selected by screening of immune individuals may be capable of exacerbating disease in genetically susceptible individuals.

Successful treatment of drug-resistant cutaneous leishmaniasis in humans by use of imiquimod, an immunomodulator.

  • I. ArevaloB. Ward A. Llanos-Cuentas
  • Medicine, Biology
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
  • 2001
An open-label, prospective study was conducted of combined imiquimod plus meglumine antimonate therapy in 12 patients with cutaneous leishmaniasis who had previously not responded to meglumsent antimonates, and 90% were found to be cured at the 6-month follow-up period.

The reemergence of visceral leishmaniasis in Brazil.

The appearance of the South American arenaviruses illustrates how exploitation of new areas for human settlement and agriculture increases the likelihood that new infectious diseases will emerge.

Miltefosine, an oral agent, for the treatment of Indian visceral leishmaniasis.

Orally administered miltefosine appears to be an effective treatment for Indian visceral leishmaniasis.